MALKAN PILIPOVIC: Open Payments
NPI 1356034532 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 119 payments from 19 companies in 2025. Trend: 2023 $232 · 2024 $2,014 · 2025 $2,410
Food & beverage: $2,391Education: $19
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $448 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $278 |
| Vanda Pharmaceuticals Inc. | 15 | $274 |
| ABBVIE INC. | 14 | $267 |
| Axsome Therapeutics, Inc. | 4 | $188 |
| Corium, LLC | 6 | $157 |
| Janssen Pharmaceuticals, Inc | 11 | $154 |
| Lundbeck LLC | 7 | $143 |
| E.R. Squibb & Sons, L.L.C. | 10 | $139 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, Auvelity, Azstarys, SPRAVATO, COBENFY.
Industry payments across IA — which companies pay providers there.
